Wang Haihong, Xu Shengyuan, Sun Liyuan, Pan Xiaodong, Yang Shiwei, Wang Luya
Department of Atherosclerosis, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China.
PLoS One. 2014 Mar 26;9(3):e92703. doi: 10.1371/journal.pone.0092703. eCollection 2014.
Familial hypercholesterolemia (FH) is an autosomal dominant disease that primarily results from mutations in the low-density lipoprotein receptor (LDLR) gene. We investigated two unrelated Chinese FH patients using gene screening and functional analysis to reveal the pathogenicity and the mechanism by which these mutations cause FH.
First, the LDLR gene was sequenced in these patients. Then, mutant receptors were transfected into human embryo kidney 293 (HEK-293) cells, and a confocal laser-scanning microscope was used to observe the localization of mutant proteins. Further, the expression and the internalization activity were analyzed by flow cytometry. Finally, LDLR protein expression and stability was detected by western blot.
Two different LDLR class 2B mutations were detected in two patients. The C201F mutation is a known mutation. However, the G615V mutation is novel. Flow cytometry showed that the expression and internalization activity of the mutant LDLRs were reduced to 73.6% and 82.6% for G615V and 33.2% and 33.5% for C201F, respectively.
This study identified two LDLR mutations in Chinese patients with FH and analyzed the relationship between the genotype and phenotype of these patients. We found that these mutant LDLRs were defective in transport, which led to a reduction in cholesterol clearance. These results increase our understanding of the mutational spectrum of FH in the Chinese population.
家族性高胆固醇血症(FH)是一种常染色体显性疾病,主要由低密度脂蛋白受体(LDLR)基因突变引起。我们通过基因筛查和功能分析对两名无血缘关系的中国FH患者进行研究,以揭示这些突变导致FH的致病性和机制。
首先,对这些患者的LDLR基因进行测序。然后,将突变受体转染到人胚肾293(HEK-293)细胞中,并用共聚焦激光扫描显微镜观察突变蛋白的定位。此外,通过流式细胞术分析其表达和内化活性。最后,通过蛋白质印迹法检测LDLR蛋白的表达和稳定性。
在两名患者中检测到两种不同的LDLR 2B类突变。C201F突变是已知突变。然而,G615V突变是新发现的。流式细胞术显示,G615V突变的LDLR的表达和内化活性分别降至73.6%和82.6%,C201F突变的LDLR则分别降至33.2%和33.5%。
本研究在中国FH患者中鉴定出两种LDLR突变,并分析了这些患者的基因型与表型之间的关系。我们发现这些突变的LDLR在转运方面存在缺陷,这导致胆固醇清除率降低。这些结果增进了我们对中国人群中FH突变谱的了解。